Su Bin, Fu Yuping, Liu Yan, Wu Haoquan, Ma Ping, Zeng Weiping, Zhang Tong, Lian Shi, Wu Hao
Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing, China.
Beijing Key Laboratory for HIV/AIDS Research, Beijing, China.
Front Microbiol. 2018 Dec 21;9:3185. doi: 10.3389/fmicb.2018.03185. eCollection 2018.
MicroRNAs (miRNAs) were first identified in and later recognized as playing pivotal roles in a vast range of cellular activities. It has been shown that miRNAs are an important mechanism not only for host defense against virus but also for the establishment of viral infection. During human immunodeficiency virus type 1 (HIV-1) infection, host miRNA profiles are altered either as a host response against the virus or alternatively as a mechanism for the virus to facilitate viral replication and infection or to maintain latency. The altered miRNA profiles can be detected and quantified by various advanced assays, and potentially serve as more sensitive, accurate and cost-efficient biomarkers for HIV-1 diagnosis and disease progression than those detected by currently available standard clinical assays. Such new biomarkers are critical for optimizing treatment regimens. In this review, we focus on the potential application of miRNA profiling to the diagnosis of HIV-1 infection and the monitoring of disease progression.
微小RNA(miRNA)于[具体时间]首次被发现,随后被认为在广泛的细胞活动中发挥关键作用。研究表明,miRNA不仅是宿主抵御病毒的重要机制,也是病毒建立感染的重要机制。在人类免疫缺陷病毒1型(HIV-1)感染期间,宿主miRNA谱会发生改变,这既可能是宿主对病毒的反应,也可能是病毒促进病毒复制和感染或维持潜伏状态的一种机制。通过各种先进检测方法可以检测和量化这些改变的miRNA谱,与目前可用的标准临床检测方法相比,它们有可能作为HIV-1诊断和疾病进展更敏感、准确且经济高效的生物标志物。此类新的生物标志物对于优化治疗方案至关重要。在本综述中,我们重点关注miRNA谱在HIV-1感染诊断和疾病进展监测中的潜在应用。